Joanne M. Donovan

CIK 1644087 · CMO · last filed 2026-05-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$152.1K

Companies

2

Total Filings

24

Lifetime Open-Market Net

-$4.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX CMO 4,367 $34.83 $152.1K -$4.64M 15 2026-05-05
Astria Therapeutics, Inc. (CATB) Delisted CMO; SVP Clinical Development 409 $8.54 $3.5K $0 9 2020-02-14

Recent Filings · Page 2 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-03 EWTX Mixed +7,162 -$29.0K EDGAR
2022-08-10 EWTX Grant (A) $0 EDGAR
2022-05-03 EWTX Grant (A) $0 EDGAR
2021-08-19 EWTX Grant (A) $0 EDGAR
2021-05-04 EWTX Grant (A) $0 EDGAR
2020-02-14 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
2019-02-15 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
2018-09-11 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
2018-02-09 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
2017-02-10 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
Showing 1120 of 24
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.